Journal article icon

Journal article

Reactive astrocytes mediate toxicity in iPSC derived dopaminergic neurons

Abstract:
Neuroinflammation is a hallmark of Parkinson's disease (PD), a progressive neurodegenerative disorder characterized by the accumulation of α-synuclein and the death of dopaminergic neurons in the substantia nigra. Mutations in GBA are a common risk factor for PD, which can lead to lipid metabolism dysfunction, autophagy/lysosomal dysregulation, as well as the disruption of other cellular functions. In this study, we investigated the impact of the GBA-N370S mutation and astrocytic reactivity on α-synuclein pathology and neurotoxicity. To investigate the impact of reactive astrocytes on Parkinson's disease pathology, we employed iPSC-derived midbrain astrocyte and dopaminergic neuron co-cultures from control and GBA-N370S donors, as well as primary mouse midbrain astrocyte cultures and transcriptomic assays to examine the response of astrocytes to Tumor Necrosis Factor-α (TNFα) and Interferon-γ (IFNγ). We show that upon inflammatory stimuli astrocytes become reactive, leading to extensive transcriptional changes. RNAseq and experimental validation revealed that calcium transport and homeostasis were severely dysregulated, and functional studies confirmed that GBA-N370S astrocytes exhibited increased calcium release when treated with cytokines. We further explored the impact of inflammation on astrocytic neurosupport in an iPSC-derived dopaminergic neuron and astrocyte co-culture model finding that combined treatment of TNFα, IFNγ and α-synuclein pre-formed fibrils (PFFs) led to neurotoxic effects, suggesting that TNFα and IFNγ-activated astrocytes mediate α-synuclein PFF toxicity. Taken together, these data provide evidence of reduced neurosupport in both control and GBA-N370S iPSC-derived midbrain astrocytes exposed to inflammatory cytokines, suggesting a role for reactive astrocytes in PD pathology.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1038/s41531-026-01378-9

Authors

More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Role:
Author
ORCID:
0009-0006-4768-9089
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0009-0008-4907-4330
More by this author
Role:
Author
ORCID:
0000-0002-2642-1183
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-0297-6675


Publisher:
Nature Research
Journal:
npj Parkinson's Disease More from this journal
Publication date:
2026-06-12
DOI:
EISSN:
2373-8057
ISSN:
2373-8057


Language:
English
Keywords:
Pubs id:
2433820
Local pid:
pubs:2433820
Source identifiers:
W7164551777
Deposit date:
2026-06-17
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP